Viewing nowYushita Tablets 50 mg (Sitagliptin Hydrochloride Hydrate)
Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
YuYoung Pharmaceutical Co., Ltd.

MFDS item code 202101746 · Approved 2021.02.22 · Insurance code 648204600
Improvement in blood glucose control in type 2 diabetes
This medication is used to assist in the improvement of blood glucose control in patients with type 2 diabetes, in conjunction with dietary therapy and exercise therapy. It can be administered alone, but if previous diabetes medication experience is absent and blood glucose control is difficult with monotherapy, it can be used in combination with metformin. Furthermore, when sufficient blood glucose control is not achievable with monotherapy or in combination with sulfonylureas, metformin, thiazolidinediones, or insulin, this medication can be added to enhance treatment effects. Thus, it effectively improves blood glucose control in type 2 diabetes when used alongside various pharmacotherapy.
This medication is administered once daily at 100 mg for both monotherapy and combination therapy, with a maximum daily dosage of 100 mg. It can be taken regardless of meals. For patients with renal impairment, dosage adjustments are necessary. - Mild and moderate renal impairment (eGFR 45 or greater and less than 90) do not require dosage adjustments. - For moderate renal impairment (glomerular filtration rate 30 to less than 45), a dosage of 50 mg once daily is to be administered.
This medication can rarely cause serious allergic reactions, so if symptoms such as skin rash, hives, or difficulty breathing occur after administration, use should be discontinued immediately and medical advice should be sought. This medication may cause inflammation of the pancreas; therefore, if symptoms such as abdominal pain, vomiting, or persistent nausea occur, consult a physician immediately. Patients with type 1 diabetes or diabetic ketoacidosis should not use this medication, and it should also not be administered if there is an allergy to this medication or its components. Patients with decreased kidney function need dosage adjustments; therefore, regular kidney function tests should be conducted during treatment. Symptoms of hypoglycemia may appear while taking this medication; thus, particularly when used alongside insulin or sulfonylureas, frequent monitoring of blood glucose levels and precautions against hypoglycemia are advised. This medication can rarely cause side effects such as joint pain or blistering skin disorders; therefore, if severe joint pain or blisters appear on the skin, inform a physician immediately. Women who are pregnant or breastfeeding are advised not to take this medication, and safety and efficacy have not been established in children and adolescents under 18 years of age. In the event of overdosing, the medication should be removed from the gastrointestinal tract and appropriate monitoring, such as ECG tests, should be done; some medications may be removed by hemodialysis if necessary. This medication has relatively low drug interactions when used in combination with other diabetes treatments, but dosage adjustments might be necessary if taken with certain medications; consultation with a physician is recommended. Older adults may have decreased kidney function, so it is essential to assess kidney function before administration and adjust the dose accordingly.
Hives, severe swelling (angioedema), chest tightness, difficulty breathing, anaphylaxis, Stevens-Johnson syndrome and exfoliative dermatitis, severe rash with fever, blistering, skin peeling, oral/eye mucosal pain, acute pancreatitis, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), elevated liver enzymes, extreme lethargy, sudden and
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and kept at room temperature between 1 to 30 degrees Celsius. This way, the medication's efficacy can be maintained and deterioration can be prevented.
Bright apricot-colored, round, double-convex film-coated tablets
28 tablets/box [14 tablets/PTP x 2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
YuYoung Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.